Diabetes drug semaglutide may boost stem cells that protect blood vessels
NCT ID NCT04126603
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This study looked at whether semaglutide, a diabetes medication, can improve the number and function of certain stem cells that help protect blood vessels in people with type 2 diabetes. Ten adults with diabetes took either semaglutide or a placebo for 24 weeks. Researchers measured stem cell activity, fat tissue changes, and blood vessel stiffness to understand how the drug might improve heart health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The GW Medical Faculty Associates
Washington D.C., District of Columbia, 20037, United States
-
Washington VA Medical Center
Washington D.C., District of Columbia, 20422, United States
Conditions
Explore the condition pages connected to this study.